PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Genstar Capital makes majority investment in clinical trials specialist Flourish Research

Genstar Capital (Genstar), a PE firm focused on investments in targeted segments of the healthcare, financial services, software, and industrials industries, has acquired clinical trial specialist Flourish Research from NMS Capital.

Headquartered in Apex, NC, Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research with a focus on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas among others.

Jefferies LLC served as lead financial advisor and McDermott Will & Emery provided legal counsel to Flourish. Cantor Fitzgerald & Co. also served as financial advisor to the Company. Houlihan Lokey served as financial advisor and Ropes & Gray LLP provided legal counsel to Genstar.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured